Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2005. Start Trial.
Date Value
December 31, 2022 -0.8278
September 30, 2022 -0.818
June 30, 2022
March 31, 2022 -1.156
March 31, 2021
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 15.46
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 0.00
Date Value
June 30, 2013 0.00
March 31, 2013 0.00
December 31, 2012 0.00
September 30, 2012 0.00
June 30, 2012 0.00
March 31, 2012 0.00
December 31, 2011 0.00
September 30, 2011 0.00
June 30, 2011 0.00
March 31, 2011 0.00
December 31, 2010 0.00
September 30, 2010 0.00
June 30, 2010 0.00
March 31, 2010 0.00
December 31, 2009 0.00
September 30, 2009 0.00
June 30, 2009 0.00
March 31, 2009 0.00
December 31, 2008 0.00
September 30, 2008 0.00
June 30, 2008 0.00
March 31, 2008 0.00
December 31, 2007 0.00
September 30, 2007 0.00
June 30, 2007 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.0565
Alnylam Pharmaceuticals, Inc. 2.206
Savara, Inc. 0.2117
Vericel Corp. 0.2556
Biogen, Inc. 0.4433